Cost of cancer care varies widely based on who pays the bill
the ONA take:
Cost disparities in chemotherapy drugs can be substantial, reveals a new study from the University of North Carolina and Chapel Hill.
Researchers found uninsured patients with cancer are asked to pay on average 2 times more than Medicare recipients would pay for the same drugs, and that difference can go as high as 43 times more. The uninsured even pay more than those with private insurance.
Cost of doctor visits for cancer patients was also reviewed, and the same discrepancy in costs was seen. For example, uninsured patients were billed $129 to $391, depending on the complexity of the visit; however, Medicare and private insurance paid $65 to $188 and $78 to $246, respectively, for the same visits.
Researchers report that patients with Medicare or private insurance are paying a discounted rate for their health care. Uninsured patients do not have the bargaining power, or may not try to negotiate price on their own.
Uninsured patients with cancer are asked to pay on average 2 times more than Medicare recipients would pay for the same drugs
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Baseline PSA Levels in Midlife Could Predict Risk of Lethal Prostate Cancer
- Community Breast Navigation Program Improved Breast Screening Rates in Underserved African American and Latino Women
- Live-streamed Videos Address End-of-Life Planning, Decision-making
- Metastatic Disease Linked to Patients Reporting Diminished QoL
- History of Bilateral Salpingo-oophorectomy, Hormone Replacement Therapy Are Predictive of Breast Density at Cancer Diagnosis
- Mammographically Occult Contralateral Breast Cancer Detection is Effective With Preoperative MRI
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|